CRS Clinical Research Services Berlin GmbH
Berlin, 13627, Germany
NCT Number: NCT07526194
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 3821001 in healthy male trial participants.
This study is active but is not currently recruiting participants.
Notify Me18 year–55 year
Male
Interventional
Phase 1
Berlin, 13627, Germany
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
BI 3821001
Placebo
Time frame: Up to 60 days
Time frame: Up to 60 days
Time frame: Up to 60 days
Time frame: Up to 60 days
Boehringer Ingelheim
Industry
A Phase I Single-blind, Randomised, Placebo-controlled, Parallel Group Design Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Single Rising Doses of BI 3821001 Administered to Healthy Trial Participants
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07531628
Healthy
Hangzhou, China
View Trial DetailsNCT06934148
Attention, Healthy
Newton, Massachusetts, United States
View Trial DetailsNCT07662798
Healthy
Lenexa, Kansas, United States
View Trial DetailsNCT06565065
Healthy
Pomona, California, United States
View Trial Details